By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Waldencast plc

Waldencast plc (WALD)

NASDAQ Currency in USD
$1.81
+$0.02
+1.12%
Last Update: 12 Sept 2025, 20:00
$202.82M
Market Cap
-2.54
P/E Ratio (TTM)
Forward Dividend Yield
$1.48 - $4.40
52 Week Range

WALD Stock Price Chart

Explore Waldencast plc interactive price chart. Choose custom timeframes to analyze WALD price movements and trends.

WALD Company Profile

Discover essential business fundamentals and corporate details for Waldencast plc (WALD) to support your stock research and investment decisions.

Sector

Technology

Industry

Software - Application

IPO Date

12 May 2021

Employees

335.00

CEO

Michel Brousset

Description

Waldencast Acquisition Corp. a skin care company, provides advanced skin care treatments. Its products are designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals. Its portfolio includes Obagi Medical that provides transformational skin care products formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines, and wrinkles and to protect and enhance skin tone and texture; and Obagi Clinical that offers skin care products designed to prevent the early signs of skin aging. The company was founded in 1988 and is based in White Plains, New York.

WALD Financial Timeline

Browse a chronological timeline of Waldencast plc corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 11 May 2026

Earnings released on 18 Aug 2025

EPS came in at -$0.09 falling short of the estimated -$0.08 by -21.63%, while revenue for the quarter reached $131.58M , beating expectations by +94.48%.

Earnings released on 18 Mar 2025

EPS came in at -$0.18 falling short of the estimated -$0.05 by -260.00%, while revenue for the quarter reached $108.80M , beating expectations by +51.26%.

Earnings released on 20 Nov 2024

EPS came in at -$0.11 falling short of the estimated -$0.05 by -120.00%, while revenue for the quarter reached $109.34M , beating expectations by +55.24%.

Earnings released on 21 May 2024

EPS came in at -$1.00 falling short of the estimated $0.04 by -2.59K%, while revenue for the quarter reached $89.85M , beating expectations by +30.22%.

Earnings released on 16 Jul 2023

EPS came in at -$0.09 , while revenue for the quarter reached $76.28M , missing expectations by -22.65%.

Earnings released on 27 Apr 2023

EPS came in at -$0.22 falling short of the estimated $0.01 by -4.58K%, while revenue for the quarter reached $71.24M , beating expectations by +52.12%.

Earnings released on 11 Aug 2022

EPS came in at -$0.06 falling short of the estimated $0.01 by -700.00%, while revenue for the quarter reached $71.24M , beating expectations by +38.19%.

Earnings released on 16 May 2022

EPS came in at -$0.10 , while revenue for the quarter reached $47.21M .

WALD Stock Performance

Access detailed WALD performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run